Case Report

J Rheum Dis 2013; 20(2): 103-107

Published online April 28, 2013

© Korean College of Rheumatology

Cyclophosphamide-induced Posterior Reversible Encephalopathy Syndrome in a Patient with Lupus Nephritis

Chang-Hoon Lee1, Yu Min Lee1, Seon Ho Ahn1, Dae Woong Ryu2, Ju Hung Song1, Myeung-Su Lee1

Departments of Internal Medicine1, Thoracic and Cardiovascular Surgery2, Wonkwang University School of Medicine, Iksan, Korea

Correspondence to : Myeung-Su Lee

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurologic condition characterized by vasogenic edema on neuroimaging and is associated with the setting of severe hypertension, eclampsia, autoimmune disease, malignancy, and immunosuppressive drugs. We report on a 42 year-old female systemic lupus erythematous patient who presented altered consciousness, seizure, and visual disturbance after cyclophosphamide pulse therapy. Magnetic resonance imaging (MRI) showed multi-focal high signal intensity lesions in the parieto-occipital cortex bilaterally and in the subcortical white matter. Her condition was improved and her MRI lesions were resolved after aggressive blood pressure control and high-dose steroid treatment. It is possibly the first reported case of PRES in a patient with lupus, treated with cyclophosphamide pulse therapy during a nephritis flare in Korea.

Keywords Posterior reversible encephalopathy syndrome, Systemic lupus erythematosus, Cyclophosphamide

Article

Case Report

J Rheum Dis 2013; 20(2): 103-107

Published online April 28, 2013

Copyright © Korean College of Rheumatology.

Cyclophosphamide-induced Posterior Reversible Encephalopathy Syndrome in a Patient with Lupus Nephritis

Chang-Hoon Lee1, Yu Min Lee1, Seon Ho Ahn1, Dae Woong Ryu2, Ju Hung Song1, Myeung-Su Lee1

Departments of Internal Medicine1, Thoracic and Cardiovascular Surgery2, Wonkwang University School of Medicine, Iksan, Korea

Correspondence to:Myeung-Su Lee

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurologic condition characterized by vasogenic edema on neuroimaging and is associated with the setting of severe hypertension, eclampsia, autoimmune disease, malignancy, and immunosuppressive drugs. We report on a 42 year-old female systemic lupus erythematous patient who presented altered consciousness, seizure, and visual disturbance after cyclophosphamide pulse therapy. Magnetic resonance imaging (MRI) showed multi-focal high signal intensity lesions in the parieto-occipital cortex bilaterally and in the subcortical white matter. Her condition was improved and her MRI lesions were resolved after aggressive blood pressure control and high-dose steroid treatment. It is possibly the first reported case of PRES in a patient with lupus, treated with cyclophosphamide pulse therapy during a nephritis flare in Korea.

Keywords: Posterior reversible encephalopathy syndrome, Systemic lupus erythematosus, Cyclophosphamide

JRD
Jan 01, 2025 Vol.32 No.1, pp. 1~7
COVER PICTURE
Cumulative growth of rheumatology members and specialists (1980~2024). Cumulative distribution of the number of the (A) Korean College of Rheumatology members and (B) rheumatology specialists. (J Rheum Dis 2025;32:63-65)

Stats or Metrics

Share this article on

  • line

Related articles in JRD

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download